CD274 and breast carcinoma: In different subtypes of breast cancers, many studies have found that tumor-induced B cells highly express PD-L1, and these cells inhibit T cell proliferation and promote the formation of regulatory T cells, which can be reversed by PD-L1 antibodies34–37.